Analyst firms · Piper Sandler · SGHT
Piper Sandler SGHT price target and rating history
Sight Sciences Inc. (SGHT) · Health Care
Piper Sandler rates Sight Sciences Inc. (SGHT) Overweight with a $9 price target, as of its latest action on Jan 5, 2026. It has published 3 rating actions on SGHT since August 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a SGHT price target in the last 12 months, the median target is $9. Piper Sandler's target matches it.
- Current rating
- Overweight
- Price target
- $9
- Median target, all firms
- $9
- Actions on SGHT
- 3
Piper Sandler price target on SGHT
Every Piper Sandler rating on SGHT
- Jan 5, 2026
- Sep 12, 2023
- Aug 9, 2021
How other firms rate SGHT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| H.C. Wainwright | Buy | $14 | Oct 15, 2026 |
| UBS | Buy | $7 | Jul 28, 2026 |
| Piper Sandler | Overweight | $9 | Jan 5, 2026 |
Questions about Piper Sandler and SGHT
- What is Piper Sandler's price target for SGHT?
- Piper Sandler's latest stated price target for Sight Sciences Inc. (SGHT) is $9, from its action on Jan 5, 2026.
- What is Piper Sandler's rating on SGHT?
- Piper Sandler rates SGHT Overweight, a bullish rating, as of Jan 5, 2026.
- When did Piper Sandler last change its view on SGHT?
- On Jan 5, 2026, Piper Sandler upgrades to Overweight from Neutral, price target $9.
- How does Piper Sandler's SGHT target compare with other analysts?
- Across 3 firms with a SGHT price target in the last 12 months, the median target is $9. Piper Sandler's target matches it.
More SGHT rating histories
All Piper Sandler ratingsSGHT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.